256 related articles for article (PubMed ID: 23764845)
1. Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells.
Dando I; Donadelli M; Costanzo C; Dalla Pozza E; D'Alessandro A; Zolla L; Palmieri M
Cell Death Dis; 2013 Jun; 4(6):e664. PubMed ID: 23764845
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists.
Brandi J; Dando I; Palmieri M; Donadelli M; Cecconi D
Electrophoresis; 2013 May; 34(9-10):1359-68. PubMed ID: 23463621
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
Börner C; Smida M; Höllt V; Schraven B; Kraus J
J Biol Chem; 2009 Dec; 284(51):35450-60. PubMed ID: 19858202
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.
Echigo R; Sugimoto N; Yachie A; Ohno-Shosaku T
Oncol Rep; 2012 Oct; 28(4):1176-80. PubMed ID: 22842590
[TBL] [Abstract][Full Text] [Related]
5. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.
Donadelli M; Dando I; Zaniboni T; Costanzo C; Dalla Pozza E; Scupoli MT; Scarpa A; Zappavigna S; Marra M; Abbruzzese A; Bifulco M; Caraglia M; Palmieri M
Cell Death Dis; 2011 Apr; 2(4):e152. PubMed ID: 21525939
[TBL] [Abstract][Full Text] [Related]
7. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
Ribeiro R; Wen J; Li S; Zhang Y
Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
[TBL] [Abstract][Full Text] [Related]
8. ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK
López-Dyck E; Andrade-Urzúa F; Elizalde A; Ferrer-Villada T; Dagnino-Acosta A; Huerta M; Osuna-Calleros Z; Rangel-Sandoval C; Sánchez-Pastor E
Pharmacol Rep; 2017 Dec; 69(6):1131-1139. PubMed ID: 29128791
[TBL] [Abstract][Full Text] [Related]
9. Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria.
Maggo S; Ashton JC
J Cardiovasc Pharmacol; 2018 Oct; 72(4):191-194. PubMed ID: 30080756
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
Gomez O; Sanchez-Rodriguez A; Le M; Sanchez-Caro C; Molina-Holgado F; Molina-Holgado E
Br J Pharmacol; 2011 Aug; 163(7):1520-32. PubMed ID: 21480865
[TBL] [Abstract][Full Text] [Related]
11. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
Silva GB; Atchison DK; Juncos LI; García NH
Am J Physiol Renal Physiol; 2013 Feb; 304(4):F376-81. PubMed ID: 23220721
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor 2 activation decreases severity of cyclophosphamide-induced cystitis via regulating autophagy.
Liu Q; Wu Z; Liu Y; Chen L; Zhao H; Guo H; Zhu K; Wang W; Chen S; Zhou N; Li Y; Shi B
Neurourol Urodyn; 2020 Jan; 39(1):158-169. PubMed ID: 31729056
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells.
Pourkhalili N; Ghahremani MH; Farsandaj N; Tavajohi S; Majdzadeh M; Parsa M; Lavasani NJ; Ostad SN
Toxicol Mech Methods; 2013 Feb; 23(2):120-6. PubMed ID: 22978792
[TBL] [Abstract][Full Text] [Related]
14. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.
Vara D; Salazar M; Olea-Herrero N; Guzmán M; Velasco G; Díaz-Laviada I
Cell Death Differ; 2011 Jul; 18(7):1099-111. PubMed ID: 21475304
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
Small-Howard AL; Shimoda LM; Adra CN; Turner H
Biochem J; 2005 Jun; 388(Pt 2):465-73. PubMed ID: 15669919
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming.
Angelina A; Pérez-Diego M; López-Abente J; Rückert B; Nombela I; Akdis M; Martín-Fontecha M; Akdis C; Palomares O
Mucosal Immunol; 2022 Jan; 15(1):96-108. PubMed ID: 34548620
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
